CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization